Início › DPOC › Texas

Ensaios clínicos de DPOC em Texas

25 estudos para DPOC estão buscando participantes em locais em Texas.

Cidades em Texas

Texto oficial do estudo (Inglês)

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Horizon Clinical Research Group., Cypress
Metroplex Pulmonary and Sleep Center, McKinney
DM Clinical Research- Tomball, Tomball

RecrutandoFase 2

Idades de 40 a 85 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07684820

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

Copd01 50001, Boerne

RecrutandoFase 2

Idades de 40 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07725939

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Premier Pulmonary Critical Care and Sleep, Denison
Baylor College of Medicine Medical Center, Houston
Prime Clinical Research - Lewisville, Lewisville

RecrutandoFase 2

Idades de 40 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07759245

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont

RecrutandoFase 4

Idades de 40 a 85 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Wellness Clinical Research - Allen- Site Number : 8400085, Allen
REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
Novel Research - Bellaire- Site Number : 8400116, Bellaire
e mais 17

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

University of Texas Southwestern, Dallas

Recrutando

Idades de 40 a 80 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06035120

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

WB Contracted Clinical Research Site, McKinney
WB Contracted Clinical Research Site, Waxahachie

RecrutandoFase 2

Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07646587

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

IntraCare- Site Number : 8400034, Dallas
Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
El Paso Pulmonary Association- Site Number : 8400033, El Paso
e mais 5

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07190222

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Boerne
Research Site, Dallas
Research Site, Denison
e mais 5

RecrutandoFase 2

Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Baylor College of Medicine, Houston

RecrutandoFase 2

Idades 40 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Dallas
Research Site, Forney
Research Site, Fort Worth
e mais 5

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Boerne
Research Site, El Paso
Research Site, Houston
e mais 6

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06878261

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

The Lung & Sleep Institute of North Texas, North Richland Hills

RecrutandoEstudo observacional

Idades 40 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07612878

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
Ten20 Clinical Research, Carrollton
Horizon Clinical Research Group, Cypress
e mais 4

RecrutandoFase 2/3

Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Abilene
Research Site, Brownsville
Research Site, Dallas
e mais 12

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06283966

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

GC2501 Study Site 109, Dallas

RecrutandoFase 3

Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07555483

STRIVE Post-Market Registry Study

Baylor Scott & White Research Institute, Dallas
University of Texas Southwestern, Dallas
University of Texas Health Science Center at Houston, Houston

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Dallas
GSK Investigational Site, DeSoto
GSK Investigational Site, Greenville
e mais 6

RecrutandoFase 3

Idades de 40 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Liver Center of Texas, Dallas
Methodist Hospital, Richardson

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT05181826

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Houston Methodist/Primary Critical Care, Houston

Recrutando

Idades de 40 a 84 · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

GSK Investigational Site, Austin
GSK Investigational Site, Dallas
GSK Investigational Site, El Paso
e mais 5

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

GSK Investigational Site, Corsicana

RecrutandoFase 3

Idades de 40 a 80 · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT06959095

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Texas A&M Family Care, Bryan

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 12 de set. de 2025 · NCT06726590

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Horizon Clinical Research Group, Houston
CHRISTUS Trinity Mother Frances Health System, Tyler

RecrutandoEstudo observacional

Idades 50 e acima · Todos os sexos · Atualizado em 5 de ago. de 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Respire Research Institute, Houston

Recrutando

Idades 30 e acima · Todos os sexos · Atualizado em 6 de fev. de 2025 · NCT05204888

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.